More than another pill. More than temporary relief.
Learn how InterStim™ system targets the sacral nerves that control bladder and bowel function, which may help you get your life back.
At Medtronic, we believe you deserve more from your bladder and bowel control therapy.
If you've tried medication and lifestyle changes and haven't gotten the relief that you need, there is another option.
When more conservative treatments fail, the InterStim™ system offers discreet, personalized relief that lets you get back to the activities you love.
Hear stories from patients who suffered from bladder and bowel symptoms and see how they found lasting relief with the InterStim™ system.
Where more conservative treatments target the bladder and bowel muscles, the InterStim™ system targets the sacral nerves that control bladder and bowel function.6,7 Targeting this communication may help restore* proper function.
The NURO™ device administers a therapy called percutaneous tibial neurostimulation (PTNM). Rather than a long-term implant, this device uses acupuncture-like needle to stimulate the nerves that control bladder function.
The most common adverse events experienced during clinical studies included pain at implant sites, new pain, lead migration, infection, technical or device problems, adverse change in bowel or voiding function, and undesirable stimulation or sensations. Any of these may require additional surgery or cause return of symptoms.
Deﬁned as a 50 percent or greater reduction in your troublesome bladder or bowel symptoms
Reflects OAB patients
Under certain conditions; see approved labeling for details. Patients with InterStim™ SureScan™ MRI leads only
Siegel S, Noblett K, Mangel J, et al. Five-year follow-up results of a prospective, multicenter study of patients with overactive bladder treated with sacral neuromodulation. J Urol. 2018;199(1), 229–236.
Medtronic InterStim Therapy Clinical Summary (2018).
Hull T, Giese C, Wexner SD, et al. Long-term durability of sacral nerve stimulation therapy for chronic fecal incontinence. Dis Colon Rectum. 2013; 56(2):234–245.
Siegel S, Noblett K, Mangel J, et al. Results of a prospective, randomized, multicenter study evaluating sacral neuromodulation with InterStim therapy compared to standard medical therapy at 6-months in subjects with mild symptoms of overactive bladder. Neurourol Urodyn. 2015;34:224–230.
Foster RT, Anoia EJ, Webster GD, Amundsen CL. In patients undergoing neuromodulation for intractable urge incontinence a reduction in 24-hr pad weight after the initial test stimulation best predicts long-term patient satisfaction. Neurourol Urodyn. 2007;26(2):213–217.
Patton V, Wiklendt L, Arkwright JW, et al. The effect of sacral nerve stimulation on distal colonic motility in patients with fecal incontinence. Br J Surg. 2013;100(7):959–968.
Leng WW, Morrisroe SN. Sacral nerve stimulation for the overactive bladder. Urol Clin N Am. 2006;33:491–501.
Information on this site should not be used as a substitute for talking with your doctor. Always talk with your doctor about diagnosis and treatment information.